-
1
-
-
77952635963
-
Callenges in the quality of heparin
-
Filho NA. Callenges in the quality of heparin. Rev Bras Hematol Hemoter. 2009;31(5):306-307.
-
(2009)
Rev Bras Hematol Hemoter
, vol.31
, Issue.5
, pp. 306-307
-
-
Filho, N.A.1
-
2
-
-
45949086068
-
Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
-
(8th Edition)
-
Hirsh J, Bauer KA, Donati MB, Gould M, Samama MM, Weitz JI. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):141S-59S.
-
(2008)
Chest
, vol.133
, Issue.6 SUPPL
-
-
Hirsh, J.1
Bauer, K.A.2
Donati, M.B.3
Gould, M.4
Samama, M.M.5
Weitz, J.I.6
-
3
-
-
79959531840
-
Drug information for health care professional (USP-DI)
-
Thomson Micromedex
-
Thomson Micromedex. Drug information for health care professional (USP-DI). Thomson Micromedex 2008.
-
(2008)
Thomson Micromedex
-
-
-
4
-
-
70350316096
-
A busca de soluções para o problema das heparinas no mercado nacional
-
Gomes WJ, Braile DM. A busca de soluções para o problema das heparinas no mercado nacional. Rev Bras Cir Cardiovasc. 2009;24(2):3-4.
-
(2009)
Rev Bras Cir Cardiovasc
, vol.24
, Issue.2
, pp. 3-4
-
-
Gomes, W.J.1
Braile, D.M.2
-
5
-
-
0035108777
-
Bovine spongiform encephalopathi and variant Creutzfeldt-Jacob disease: Background, evolution and current concerns
-
Brown P, Will RG, Bradley R, Asher DM, Detwiler L. Bovine spongiform encephalopathi and variant Creutzfeldt-Jacob disease: background, evolution and current concerns. EID. 2001;7(1):6-16.
-
(2001)
EID
, vol.7
, Issue.1
, pp. 6-16
-
-
Brown, P.1
Will, R.G.2
Bradley, R.3
Asher, D.M.4
Detwiler, L.5
-
6
-
-
58049216683
-
Outbreak of adverse reactions associated with contaminated heparin
-
Blossom DB, Kallen AJ, Patel PR, Elward A, Robinson L, Gao G et al. Outbreak of adverse reactions associated with contaminated heparin. N Engl J Med. 2008;359(25):2674-2684.
-
(2008)
N Engl J Med
, vol.359
, Issue.25
, pp. 2674-2684
-
-
Blossom, D.B.1
Kallen, A.J.2
Patel, P.R.3
Elward, A.4
Robinson, L.5
Gao, G.6
-
7
-
-
77951742223
-
Changes in the USP heparin monograph and implications for clinicians
-
Smythe MA, Nutescu EA, Wittkowsky AK. Changes in the USP heparin monograph and implications for clinicians. Pharmacotherapy 2010;30(5):428-431.
-
(2010)
Pharmacotherapy
, vol.30
, Issue.5
, pp. 428-431
-
-
Smythe, M.A.1
Nutescu, E.A.2
Wittkowsky, A.K.3
-
8
-
-
84866902895
-
-
U.S.Pharmacopeia, USP Heparin Information. US Pharmacopeia 2010. Available from
-
U.S.Pharmacopeia. USP Heparin Information. US Pharmacopeia 2010. Available from: http://www.usp.org/hottopics/heparin.html.
-
-
-
-
9
-
-
53049095938
-
Heparin quality control in the Brazilian market: Implications in the cardiovascularsurgery
-
Melo EI, Pereira MS, Cunha RS, Sa MP, Mourao PA. Heparin quality control in the Brazilian market: implications in the cardiovascularsurgery. Rev Bras Cir Cardiovasc. 2008;23(2):169-174.
-
(2008)
Rev Bras Cir Cardiovasc
, vol.23
, Issue.2
, pp. 169-174
-
-
Melo, E.I.1
Pereira, M.S.2
Cunha, R.S.3
Sa, M.P.4
Mourao, P.A.5
-
10
-
-
79959519214
-
Heparinas: Momento atual
-
Filho CC, Chamone DAF, Rached RA, Mafei FH. Heparinas: momento atual. Rev Bras Cir Cardiovasc. 2008;23(2):169-174.
-
(2008)
Rev Bras Cir Cardiovasc
, vol.23
, Issue.2
, pp. 169-174
-
-
Filho, C.C.1
Chamone, D.A.F.2
Rached, R.A.3
Mafei, F.H.4
-
11
-
-
84866904027
-
-
Agência Nacional de Vigilância Sanitária, Agência Nacional de Vigilância Sanitária (Anvisa) 2010. Available from
-
Agência Nacional de Vigilância Sanitária. Banco de dados de produtos registrados das empresas de medicamentos e hemoderivados. Agência Nacional de Vigilância Sanitária (Anvisa) 2010. Available from: http://www7.anvisa.gov.br/datavisa/consulta_produto/Medicamentos/frmConsultaMedicamentos.asp.
-
Banco De Dados De Produtos Registrados Das Empresas De Medicamentos E Hemoderivados
-
-
-
12
-
-
79959502385
-
-
World Health Organization (WHO), Policy perspectives in medicine. Geneve: WHO
-
World Health Organization (WHO). Pharmacovigilance: ensuring the safe use of medicines. Policy perspectives in medicine. Geneve: WHO; 1994.
-
(1994)
Pharmacovigilance: Ensuring the Safe Use of Medicines
-
-
-
14
-
-
84866902894
-
-
Agência Nacional de Vigilância Sanitária (Anvisa), Resolução n° 4 de fevereiro de 2009
-
Agência Nacional de Vigilância Sanitária (Anvisa). Resolução n° 4 de fevereiro de 2009.
-
-
-
-
15
-
-
0037321325
-
Heparin, lowmolecular- weight heparins, and heparin pentasaccharide: Basic and clinical differentiation
-
Hoppensteadt D, Walenga JM, Fareed J, Bick RL. Heparin, lowmolecular- weight heparins, and heparin pentasaccharide: basic and clinical differentiation. Hematol Oncol Clin North Am. 2003;17(1):313-341.
-
(2003)
Hematol Oncol Clin North Am
, vol.17
, Issue.1
, pp. 313-341
-
-
Hoppensteadt, D.1
Walenga, J.M.2
Fareed, J.3
Bick, R.L.4
-
16
-
-
77952087071
-
Heparins from porcine and bovine intestinal mucosa: Are they similar drugs?
-
Aquno RS, Pereira MS, Vairo BC, Cinelli LP, Santos GR, Fonseca RJ et al. Heparins from porcine and bovine intestinal mucosa: Are they similar drugs? Thromb Haemost. 2010;103(5):1005-1015.
-
(2010)
Thromb Haemost
, vol.103
, Issue.5
, pp. 1005-1015
-
-
Aquno, R.S.1
Pereira, M.S.2
Vairo, B.C.3
Cinelli, L.P.4
Santos, G.R.5
Fonseca, R.J.6
-
17
-
-
45949103154
-
Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
-
(8th Edition)
-
Warkentin TE, Greinacher A, Koster A, Lincoff AM. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):340S-80S.
-
(2008)
Chest
, vol.133
, Issue.6 SUPPL
-
-
Warkentin, T.E.1
Greinacher, A.2
Koster, A.3
Lincoff, A.M.4
-
18
-
-
44949233239
-
The FDA and safety-beyond the heparin crisis
-
Laurencin CT, Nair L. The FDA and safety-beyond the heparin crisis. Nat Biotechnol. 2008;26(6):621-623.
-
(2008)
Nat Biotechnol
, vol.26
, Issue.6
, pp. 621-623
-
-
Laurencin, C.T.1
Nair, L.2
-
20
-
-
79959495642
-
-
U.S. Pharmacopeia. USP Statement on heparin potency unit assignmentand harmonization with the International Standard for unfractionated heparin
-
U.S. Pharmacopeia. USP Statement on heparin potency unit assignmentand harmonization with the International Standard for unfractionated heparin. 2010.
-
(2010)
-
-
-
21
-
-
85088746175
-
-
® System. Colo: Greenwood Village
-
® System. Colo: Greenwood Village; 2010.
-
(2010)
-
-
-
22
-
-
4644242157
-
Heparin-induced thrombocytopenia: Recognition, treatment, and prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
-
Warkentin T E, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):311S-37S.
-
(2004)
Chest
, vol.126
, Issue.3 SUPPL
-
-
Warkentin, T.E.1
Greinacher, A.2
-
23
-
-
33645718758
-
Recognition, treatment, and prevention of heparin-induced thrombocytopenia: Review and update
-
Greinacher A, Warkentin TE. Recognition, treatment, and prevention of heparin-induced thrombocytopenia: review and update.Thromb Res. 2006;118(2):165-176.
-
(2006)
Thromb Res
, vol.118
, Issue.2
, pp. 165-176
-
-
Greinacher, A.1
Warkentin, T.E.2
-
24
-
-
84866899689
-
-
The Uppsala Monitoring Centre (UMC). Frequency of adverse drug reactions, World Health Organization, The Uppsala Monitoring Centre; 2008. Available from
-
The Uppsala Monitoring Centre (UMC). Frequency of adverse drug reactions. 2008. World Health Organization, The Uppsala Monitoring Centre; 2008. Available from: http://www.who-umc.org/Dyn-Page.aspx?id=22684.
-
(2008)
-
-
-
25
-
-
51649129542
-
The financial impact of heparin-induced thrombocytopenia
-
Smythe MA, Koerber JM, Fitzgerald M, Mattson JC. The financial impact of heparin-induced thrombocytopenia. Chest 2008;134(3):568-73.
-
(2008)
Chest
, vol.134
, Issue.3
, pp. 568-573
-
-
Smythe, M.A.1
Koerber, J.M.2
Fitzgerald, M.3
Mattson, J.C.4
-
26
-
-
84866908484
-
-
Notivisa - Sistema de Notificação em Vigilância Sanitária, Brasília (DF): Agência Nacional de Vigilância Sanitária (Anvisa); 2010. Available from
-
Notivisa - Sistema de Notificação em Vigilância Sanitária. 2010. Brasília (DF): Agência Nacional de Vigilância Sanitária (Anvisa); 2010. Available from: http://anvisa.gov.br/hotsite/notivisa/index/htm.
-
(2010)
-
-
|